Schroeder, B., Yuan, C., Wang, H., Mohindroo, C., Zhou, H., Raffeld, M., Xi, L., Arons, E., Feurtado, J., James-Echenique, L., Calvo, K. R., Maric, I., Kreitman, R. J. (2026). Phase 2 trial of rituximab with either pentostatin or bendamustine for multiply relapsed or refractory hairy cell leukemia. Blood. https://doi.org/10.1182/blood.2025031243